loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering 7326708

    Client Virtual Booth
    Menu

    Merck & Co

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    SERVICES

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 MERCK SHARP DOHME (9)

    02 MSD SUB MERCK (7)

    filter

    01 7326708 (16)

    filter

    01 Y (16)

    filter

    01 Y (16)

    filter

    01 2026-04-11 (6)

    02 2026-11-24 (10)

    refreshReset Filter
    refreshReset Filter
    price-trendAsk Us

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SIMVASTATIN; SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-04-11
    U-1188
    202343
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SIMVASTATIN; SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-04-11
    U-1188
    202343
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
    5
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SIMVASTATIN; SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-04-11
    U-1188
    202343
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
    4
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SIMVASTATIN; SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-04-11
    U-1188
    202343
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
    3
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-11-24
    U-802
    21995
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
    3
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-11-24
    U-802
    21995
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-11-24
    U-802
    21995
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SIMVASTATIN; SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-04-11
    U-1188
    202343
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
    6
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SIMVASTATIN; SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-04-11
    U-1188
    202343
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MSD SUB MERCK

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag India
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE

      PDF Supplier PDF
      URL Supplier Web Content
      7326708
      Y
      Y
      2026-11-24
      U-802
      22044
      METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
      2
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Post Enquiry
      POST ENQUIRY